广州谷森制药有限公司

公司在上海、南昌，广州和宁波设有研发中心。有三个吸入软雾制剂品种入选国家十三.五“重大新药创制”科技重大专项。吸入软雾剂研发和产业化走在国内外同行的前列。公司已开发了丰富的产品线。而且许多后备产品，这些产品有约200亿美元的全球市场。公司开发和申请了一系列吸入软雾剂专利，占领了该领域的制高点。为国内*获得吸入软雾剂国家“重大专项”的企业。 Our Purpose We aim fbetter life of the worldwide patients by providing medicines through integrating quality, reliability, consistency innovation. Anovent Pharmaceutical was established in 2014 as a leading pharmaceutical company that develops a new generation of high-quality, efficient, safe affordable inhalation medicines (both generic innovative pharmaceuticals) fpeople around the world. Our company has established an internationally known R&D team industrial manufacturing base. We have three R&D centers located in Shanghai, Nanchang, Guangzhou Ningbo, a pilot industrial manufacturing base in Nanchang. A number of inhalation medicines have been awarded as "MajSpecial Project" the Chinas National Thirteenth-Five Year science technology. The company has developed a rich product line consisting of several 505(b) 2 innovative drugs which have a global market of about US$20 billion. The development commercialization of these products are in the forefront around world. We have developed filed a series of patents it is the only enterprise in the country that has obtained "MajSpecial Project" fmanufacturing developing highly efficient safe inhalation prod